NovaBay Pharmaceuticals, Inc.

NBY · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$430$3,130$5,362$7,504
Short-Term Investments$0$0$0$0
Receivables$389$759$2,016$1,686
Inventory$765$2,877$3,437$3,220
Other Curr. Assets$351$388$517$760
Total Curr. Assets$1,935$7,154$11,332$13,170
Property Plant & Equip (Net)$1,008$1,383$1,950$604
Goodwill$0$0$348$4,528
Intangibles$0$0$2,280$5,200
Long-Term Investments$477$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$3$497$489$476
Total NC Assets$1,488$1,880$5,067$10,808
Other Assets$0$0$0$0
Total Assets$3,423$9,034$16,399$23,978
Liabilities
Payables$623$1,130$1,080$1,045
Short-Term Debt$963$1,632$453$305
Tax Payable$0$0$0$0
Deferred Revenue$488$0$1,807$1,289
Other Curr. Liab.$769$1,516$917$803
Total Curr. Liab.$2,843$4,278$4,257$3,442
LT Debt$709$1,108$1,588$246
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$334$0$10,119
Total NC Liab.$709$1,442$1,588$10,365
Other Liabilities$0$0$0$0
Cap. Leases$1,107$1,603$2,041$446
Total Liabilities$3,552$5,720$5,845$13,807
Equity
Pref Stock$6$1,950$2,973$680
Common Stock$49$112$20$478
Retained Earnings-$183,457-$174,849-$158,152-$141,887
AOCI$0$0$0$0
Other Equity$183,273$176,101$165,713$150,900
Total Equity-$129$3,314$10,554$10,171
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$3,423$9,034$16,399$23,978
Net Debt$1,242-$390-$3,321-$6,953
NovaBay Pharmaceuticals, Inc. (NBY) Financial Statements & Key Stats | AlphaPilot